• 135
  • 11
  • Favorite

Ocugen Jumped Over 10% in Morning Trading

Tiger Newspress2022-02-22

Ocugen jumped over 10% in morning trading.

FDA has lifted its clinical hold on the Company’s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152, known as COVAXIN™ outside the United States.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment11

  • Remotecam
    ·2022-02-23
    It was going so well until someone at top decided to dilute the stock with millions of common shares.  Face palm .... 
    Reply
    Report
  • QQXTZ
    ·2022-02-23
    Nice
    Reply
    Report
  • ARIESan
    ·2022-02-23
    Another one 
    Reply
    Report
  • riserr
    ·2022-02-23
    Ok
    Reply
    Report
  • Gladys8jk
    ·2022-02-23
    Ok
    Reply
    Report
  • Serenearies
    ·2022-02-23
    Then it dropped back in post-market... 😭
    Reply
    Report
  • 丹尼尔8333
    ·2022-02-23
    To the 🌙🌙🌙🌙 $12!!!
    Reply
    Report
  • 来人
    ·2022-02-23
    Nice
    Reply
    Report
  • Nasbhai
    ·2022-02-23
    Come on Ocugen. Defy the odds
    Reply
    Report
  • JassyJas
    ·2022-02-23
    Ok
    Reply
    Report
  • Qwer1234
    ·2022-02-22
    Ok
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial